Navigating Pancreatic Cancer
We are here to empower you to ask bold questions, seek out the best treatment options, and face the unique challenges of pancreatic cancer head-on. We want to give you the resources and information you need to make informed decisions that are best for you.
As overwhelming as a pancreatic cancer diagnosis is, it is important to act quickly and put a treatment plan into place. Treatment should ideally begin within one month after you receive your diagnosis. Understand your disease. Thoroughly understand what stage of pancreatic cancer you have and inquire about having your blood and tumor genetically sequenced. […]
If you have been diagnosed with pancreatic cancer, a clinical trial may be your best treatment option. Many clinical trials are underway for patients in all stages of the disease and may involve new combinations of currently available drugs or new drugs that have worked in other cancers. No matter where you are in your journey, we encourage you to learn more about clinical trials.
LET’S WIN! Pancreatic Cancer A Dynamic Way to Share Information Recognizing that there is an urgent need for patients to communicate amongst themselves and with the medical community about potentially life-changing treatments and clinical trials, we are proud to be affiliated with Let’s Win. Let’s Win is an interactive online community where patients and families […]
Pancreatic Cancer Connections is online social community that provides a safe space for pancreatic cancer patients and their loved ones to share their experiences, get valuable coping resources, and support one another. Patients interact with others who are facing a pancreatic cancer and can post questions to the board or message other members privately. This community forum is a valuable resource for patients, caregivers, and their loved ones to refer to at various stages of their treatment and recovery.
Patients and loved ones can sign up for Pancreatic Cancer Connections at no cost and will be welcomed into an engaging and supportive community to discuss topics including treatment options, nutrition, and coping with the disease. Pancreatic Cancer Connections is hosted by Inspire, a leading healthcare social network that connects more than 1,000,000 patients and caregivers.
New Therapies Challenge Grant
Lustgarten Foundation and Stand Up To Cancer, strategic partners in the Pancreatic Cancer Collective, offer comments on research published today in the journal Nature Medicine which describes a new therapeutic approach with promise for patients with pancreatic cancer. These researchers discovered a combination drug therapy that may effectively combat the disease. Based on this research, Martin McMahon, PhD, a cancer researcher at Huntsman Cancer Institute and professor of Dermatology at the University of Utah has received a Pancreatic Cancer Collective New Therapies Challenge Grant.
Northwell Health Announces Sponsorship
Northwell Health a Presenting Sponsor of Five Walks
We are pleased to announce that Northwell Health Cancer Institute will be a presenting sponsor for our five Lustgarten Pancreatic Cancer Research Walks in the New York metropolitan area. With the support of Northwell Health, we will raise even more awareness and funding for pancreatic cancer research at our upcoming walks in New York City, Westchester, Brooklyn, Staten Island, and Long Island.
Our walks offer patients, survivors, and loved ones a day of hope where everyone is united in the shared goal of bringing awareness to this challenging disease. Together with Northwell Health, we are determined to raise critical funds for pancreatic cancer research and improve the survival outcomes for patients.
The Northwell Health Cancer Institute is in the early stages of developing a comprehensive pancreatic cancer center. The program’s major components will include surgical, radiation and medical oncology, interventional gastroenterology, pathology, radiology, endocrinology, palliative oncology, cancer genetics, nutritional counseling, social work and other services.
If you live in the New York metropolitan area, we encourage you to attend one of our five Northwell Health-sponsored walks, visit the Northwell Health tent on site, and learn more about our joint commitment to changing patients’ lives and working toward a cure for pancreatic cancer.
Learn more about pancreatic cancer, including information on diagnosis, treatment options, and clinical trials.
Walk For Research
Where 100% of Every Dollar Raised Goes Directly to Pancreatic Cancer Research.
Alex Trebek’s Announcement
“Keep the faith and we’ll win.” — Alex Trebek
On March 6th, television icon Alex Trebek, who has hosted Jeopardy, America’s Favorite Quiz Show®, since 1984, announced that he was diagnosed with Stage IV pancreatic cancer in a video posted to the show’s official YouTube account. On behalf of our community of patients, caregivers, researchers, loved ones and survivors all impacted by this disease, we are sending Mr. Trebek our thoughts and best wishes for his treatment and recovery.
Mr. Trebek joins more than 56,000 other Americans who will be diagnosed this year. Pancreatic cancer is often called a silent disease because many times no signs or symptoms are noticed until the cancer is in an advanced stage, when surgery is typically not an option and effective treatments are limited.
Mr. Trebek is not letting this prognosis discourage him from fighting. As he shares in his video message, “I plan to beat the low survival rate statistics for this disease…Keep the faith and we’ll win. We’ll get it done.”
At the Lustgarten Foundation, we are relentlessly focused on “getting it done.” Pancreatic cancer research is moving faster than ever before, and there has never been a more hopeful time for patients. The researchers we fund are committed to identifying new treatments and tailoring therapy to each patient. We are dedicated to changing patients’ lives and making sure that many more patients become long-term survivors.
Today and every day, we stand with Mr. Trebek, his loved ones and fans, and the thousands of other patients courageously fighting this disease and inspiring us to support even more research. Please know we are with you as you navigate through this disease, and we will not quit until a cure is found.
What is…Virtual Jeopardy! for $200
Beginning on Friday, March 15, join past Jeopardy! contestants as they tune in each night and play along to raise money for pancreatic cancer research. When you choose to play for the Lustgarten Foundation, you will donate $1 to our research program for each question you answer correctly. Players can live stream themselves answering the questions and tag friends on Facebook to join in to raise even more awareness and funding for pancreatic cancer research.
Tune in to Jeopardy! when it airs in your area and share your participation on Facebook using the hashtag #jplayalongchallenge and tag @LustgartenFDN so we can see who is playing along.
KWWL.com: Pancreatic Cancer Remission Rates Remain Low
Boston25 News: Dana-Farber Pancreatic Cancer Specialist Talks Symptoms, Treatments for Disease
News12: Longtime ‘Jeopardy’ Host Alex Trebek Announces Stage 4 Pancreatic Cancer Diagnosis
PIX 11: Fight for Survival
Pancreatic Cancer NewsView All Articles
We can help people at risk, but it is much more challenging if most people think that early detection and prevention are impossible. Pancreatic cancer has a bad reputation. It is a terrible disease, but most people do not realize there are ways that early detection can help. When the “Jeopardy!” host, Alex Trebek, announced […]
With pancreatic cancer, the goal is to cure as many patients as possible through surgery. Unfortunately, by the time most patients receive their diagnosis, they are ineligible for this treatment, so it is crucial to have a host of options available — some of which might be used in combination or in tandem, according to […]
PANCREATIC CANCER IS one of the deadliest cancers for patients in the U.S. There is no denying the unsettling statistics. According to figures compiled by the Pancreatic Cancer Action Network, or PanCAN: Pancreatic cancer is the third-leading cause of cancer-related death in the U.S., behind only lung cancer and colorectal cancer, and is expected to become the […]
ROCHESTER, Minn. — Mayo Clinic researchers have identified a gene called “UCP-1” that may predict the development of pancreatic cancer in people with Type 2 diabetes. Their findings are published in Gastroenterology. “Developing strategies for the early detection of pancreatic cancer in people without symptoms is critical for improving survival,” says Suresh Chari, M.D., a Mayo […]
According to the American Cancer Society, pancreatic cancer accounts for about 3 percent of all cancers in the U.S. and about 7 percent of all cancer deaths. In 2019, the ACS estimates: About 56,770 people (29,940 men and 26,830 women) will be diagnosed with pancreatic cancer. About 45,750 people (23,800 men and 21,950 women) will […]
ACCORDING TO THE LATEST data released by the American Cancer Society, cancer deaths have declined by more than one-quarter (27 percent) over a 25-year span, from 1991 to 2016. But countering that trend, obesity-related cancer is increasing. Previous research indicates that, as noted in the ACS’ Cancer Facts & Figures 2019 report: “An estimated 5% […]
PANCREATIC CANCER IS SO difficult to treat in large part because it often isn’t discovered until the disease has spread to other parts of the body. That’s because in many cases there are no signs or symptoms until the cancer has reached an advanced stage. Even when there are early signs and symptoms, they are […]
Researchers at Allegheny Health Network Cancer Institute and Johns Hopkins Kimmel Cancer Center are teaming up to study the link between obesity and pancreatic cancer. Researchers plan to study new treatments, potential screening methods and modifiable risk factors for pancreatic cancer, which includes obesity.
The research, led by Queen Mary University of London, The Institute of Cancer Research, London, Beaujon University Hospital (INSERM), Paris, and Barts Health NHS Trust, could lead to tailor-made treatments, including immunotherapies, which target the powerful scar tissue wall that protects the cancer and makes it such a difficult disease to treat. Co-lead researcher Professor […]
BioLineRx Receives Orphan Drug Designation From the FDA for its Lead Therapeutic Candidate BL-8040 for the Treatment of Pancreatic Cancer
BioLineRx Ltd. (NASDAQ: BLRX) (TASE:BLRX), a clinical-stage biopharmaceutical company focused on oncology, announced today that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation to its lead oncology candidate, BL-8040, for the treatment of pancreatic cancer. “Orphan Drug Designation in pancreatic cancer is a very important milestone in the development plan of […]